Position in ABCL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,797,485
-$1,699,376 QoQ
Shares Held
228,979
-70.3% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 150 holders
Holding Since
Mar 2021
8 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Man Group plc holds $1,094,353,895 across 113 Biotechnology names. ABCL ranks #63 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
436,956 | $272,459,544 | |
| 2 | INCY |
Incyte Corp
|
952,941 | $108,025,391 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
307,463 | $87,617,731 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
139,233 | $69,161,207 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
397,000 | $52,693,809 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
170,907 | $51,448,133 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
152,877 | $36,838,770 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
173,439 | $32,481,655 |
All Filings in ABCL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,797,485 | 228,979 | Shares | Defined | 2026-08-14 | |
| 2024-03-31 | $3,496,861 | 771,934 | Shares | Defined | 2024-05-15 | |
| 2022-12-31 | $3,094,491 | 305,478 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,581,023 | 665,422 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,042,659 | 191,799 | Principal | Defined | 2022-08-15 | |
| 2021-09-30 | $985,266 | 49,165 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,008,854 | 45,857 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,538,557 | 45,305 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||